Literature DB >> 25362533

On the transmethylation hypothesis: stress, N,N-dimethyltryptamine, and positive symptoms of psychosis.

Dionysios Grammenos1, Steven A Barker.   

Abstract

Past research suggests a relationship between stress and positive symptoms of psychosis. However, the biological substrate of this relationship remains unknown. According to the transmethylation hypothesis, schizophrenia could result from a biochemical disruption in the stress mechanism. This biochemical disruption would lead to the production of a substance that would account for the symptoms of psychosis. Moreover, some studies have tested endogenous N,N-dimethyltryptamine (DMT) in the context of the transmethylation hypothesis. Stress has been found to elevate DMT levels in rodents. Also, elevated DMT levels have been associated with positive features of psychosis in psychiatric patients. Additionally, healthy participants treated with exogenous DMT experience predominantly positive symptoms of psychosis. The present paper examines endogenous DMT as a possible biological mediator of the relationship between stress and positive symptoms of psychosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25362533     DOI: 10.1007/s00702-014-1329-5

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  55 in total

1.  Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex.

Authors:  Elizabeth A Pehek; Christine Nocjar; Bryan L Roth; Tara A Byrd; Omar S Mabrouk
Journal:  Neuropsychopharmacology       Date:  2006-02       Impact factor: 7.853

2.  Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor.

Authors:  J R Bunzow; M S Sonders; S Arttamangkul; L M Harrison; G Zhang; D I Quigley; T Darland; K L Suchland; S Pasumamula; J L Kennedy; S B Olson; R E Magenis; S G Amara; D K Grandy
Journal:  Mol Pharmacol       Date:  2001-12       Impact factor: 4.436

3.  Neurochemical investigations of the interaction of N,N-dimethyltryptamine with dopaminergic system in rat brain.

Authors:  P C Waldmeier; L Maître
Journal:  Psychopharmacology (Berl)       Date:  1977-04-29       Impact factor: 4.530

4.  Increased stress-induced dopamine release in psychosis.

Authors:  Romina Mizrahi; Jean Addington; Pablo M Rusjan; Ivonne Suridjan; Alvina Ng; Isabelle Boileau; Jens C Pruessner; Gary Remington; Sylvain Houle; Alan A Wilson
Journal:  Biol Psychiatry       Date:  2011-11-30       Impact factor: 13.382

5.  Increased excretion of dimethyltryptamine and certain features of psychosis: a possible association.

Authors:  R M Murray; M C Oon; R Rodnight; J L Birley; A Smith
Journal:  Arch Gen Psychiatry       Date:  1979-06

6.  Reality distortion is related to the structure of the salience network in schizophrenia.

Authors:  L Palaniyappan; P Mallikarjun; V Joseph; T P White; P F Liddle
Journal:  Psychol Med       Date:  2010-12-13       Impact factor: 7.723

7.  Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.

Authors:  R J Strassman; C R Qualls; E H Uhlenhuth; R Kellner
Journal:  Arch Gen Psychiatry       Date:  1994-02

8.  Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects.

Authors:  R J Strassman; C R Qualls
Journal:  Arch Gen Psychiatry       Date:  1994-02

9.  [Methylated and unmethylated indolamine in the cisternal fluid in acute endogenous psychoses].

Authors:  R Uebelhack; L Franke; K Seidel
Journal:  Biomed Biochim Acta       Date:  1983

10.  Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors.

Authors:  R L Smith; H Canton; R J Barrett; E Sanders-Bush
Journal:  Pharmacol Biochem Behav       Date:  1998-11       Impact factor: 3.533

View more
  7 in total

Review 1.  Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.

Authors:  Rafael G Dos Santos; José Carlos Bouso; Jaime E C Hallak
Journal:  Ther Adv Psychopharmacol       Date:  2017-02-23

Review 2.  N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine.

Authors:  Edward James; Joachim Keppler; Thomas L Robertshaw; Ben Sessa
Journal:  Hum Psychopharmacol       Date:  2022-02-17       Impact factor: 2.130

Review 3.  Neuropharmacology of N,N-dimethyltryptamine.

Authors:  Theresa M Carbonaro; Michael B Gatch
Journal:  Brain Res Bull       Date:  2016-04-25       Impact factor: 4.077

Review 4.  N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function.

Authors:  Steven A Barker
Journal:  Front Neurosci       Date:  2018-08-06       Impact factor: 4.677

Review 5.  Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.

Authors:  Henry Lowe; Ngeh Toyang; Blair Steele; Justin Grant; Amza Ali; Lorenzo Gordon; Wilfred Ngwa
Journal:  Molecules       Date:  2022-04-14       Impact factor: 4.927

Review 6.  Indolethylamine-N-methyltransferase Polymorphisms: Genetic and Biochemical Approaches for Study of Endogenous N,N,-dimethyltryptamine.

Authors:  Jon G Dean
Journal:  Front Neurosci       Date:  2018-04-23       Impact factor: 4.677

7.  Targeting INMT and interrupting its methylation pathway for the treatment of castration resistant prostate cancer.

Authors:  Shangwei Zhong; Ji-Hak Jeong; Changhao Huang; Xueyan Chen; Shohreh Iravani Dickinson; Jasreman Dhillon; Li Yang; Jun-Li Luo
Journal:  J Exp Clin Cancer Res       Date:  2021-09-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.